Eurobio Scientific SA (PA:ALERS) — Market Cap & Net Worth
Market Cap & Net Worth: Eurobio Scientific SA (ALERS)
Eurobio Scientific SA (PA:ALERS) has a market capitalization of $236.10 Million (€201.95 Million) as of June 21, 2026. Listed on the PA stock exchange, this France-based company holds position #15972 globally and #231 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Eurobio Scientific SA's stock price €22.20 by its total outstanding shares 10068279 (10.07 Million). Review Eurobio Scientific SA total liabilities to assess the company's total debt and financial obligations.
Eurobio Scientific SA Market Cap History: 2015 to 2026
Eurobio Scientific SA's market capitalization history from 2015 to 2026. Data shows growth from $105.70 Million to $261.31 Million (8.43% CAGR).
Index Memberships
Eurobio Scientific SA is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
CAC PME
CAPME
|
$39.56 Billion | 0.60% | #15 of 34 |
Weight: Eurobio Scientific SA's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Eurobio Scientific SA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Eurobio Scientific SA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.92x
Eurobio Scientific SA's market cap is 1.92 times its annual revenue
Latest Price to Earnings (P/E) Ratio
74.30x
Eurobio Scientific SA's market cap is 74.30 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $105.70 Million | $29.78 Million | -$5.88 Million | 3.55x | N/A |
| 2016 | $68.27 Million | $27.82 Million | -$7.73 Million | 2.45x | N/A |
| 2017 | $55.56 Million | $42.78 Million | -$9.97 Million | 1.30x | N/A |
| 2018 | $36.08 Million | $51.07 Million | -$2.77 Million | 0.71x | N/A |
| 2019 | $55.21 Million | $59.48 Million | $3.15 Million | 0.93x | 17.51x |
| 2020 | $199.52 Million | $188.86 Million | $73.48 Million | 1.06x | 2.72x |
| 2021 | $316.87 Million | $184.71 Million | $60.54 Million | 1.72x | 5.23x |
| 2022 | $239.66 Million | $152.61 Million | $24.94 Million | 1.57x | 9.61x |
| 2023 | $193.75 Million | $130.65 Million | $4.83 Million | 1.48x | 40.07x |
| 2024 | $297.21 Million | $154.95 Million | $4.00 Million | 1.92x | 74.30x |
Competitor Companies of ALERS by Market Capitalization
Companies near Eurobio Scientific SA in the global market cap rankings as of June 21, 2026.
Key companies related to Eurobio Scientific SA by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #147 globally with a market cap of $153.73 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #207 globally with a market cap of $117.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #234 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #247 globally with a market cap of $101.86 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #147 | Abbott Laboratories | NYSE:ABT | $153.73 Billion | $88.41 |
| #207 | Stryker Corporation | NYSE:SYK | $117.79 Billion | $307.80 |
| #234 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #247 | Medtronic PLC | NYSE:MDT | $101.86 Billion | $79.34 |
Eurobio Scientific SA Historical Marketcap From 2015 to 2026
Between 2015 and today, Eurobio Scientific SA's market cap moved from $105.70 Million to $ 261.31 Million, with a yearly change of 8.43%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €261.31 Million | -8.83% |
| 2025 | €286.62 Million | -3.56% |
| 2024 | €297.21 Million | +53.40% |
| 2023 | €193.75 Million | -19.16% |
| 2022 | €239.66 Million | -24.37% |
| 2021 | €316.87 Million | +58.82% |
| 2020 | €199.52 Million | +261.41% |
| 2019 | €55.21 Million | +53.02% |
| 2018 | €36.08 Million | -35.06% |
| 2017 | €55.56 Million | -18.62% |
| 2016 | €68.27 Million | -35.42% |
| 2015 | €105.70 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 20th, 2026 the market cap of Eurobio Scientific SA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $236.10 Million USD |
| MoneyControl | $236.10 Million USD |
| MarketWatch | $236.10 Million USD |
| marketcap.company | $236.10 Million USD |
| Reuters | $236.10 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Eurobio Scientific SA
Eurobio Scientific Société anonyme engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and oncology. It commercializes media for the transportation and preservation of cornea grafts, as well as a device to facilitate the corresponding surgery; AlloMap, for heart transplant monito… Read more